Pentasa Sachet 1 gm is prescribed for the treatment of ulcerative colitis and Crohn’s disease. Ulcerative colitis is a chronic inflammatory bowel disease that leads to inflammation of the lining of the large intestine (colon). This condition can result in ulcers on the colon’s lining, potentially causing bleeding and the discharge of pus and mucus.
Pentasa Sachet 1 gm contains Mesalazine, which functions by inhibiting the production of certain chemicals, including prostaglandins, that are responsible for pain and swelling.
You may experience side effects such as diarrhoea, stomach pain, headache, nausea, vomiting, or flatulence (gas). Most of these side effects associated with Pentasa Sachet 1 gm do not necessitate medical attention and typically resolve on their own over time. However, if these side effects persist or worsen, it is important to consult your doctor.
Take Pentasa Sachet 1 gm exactly as prescribed. It is recommended to use Pentasa Sachet 1 gm for the duration advised by your doctor, depending on your medical condition. The medication should be taken one hour before meals or two hours after meals. Do not exceed the recommended dosage.
Notify your doctor if you have any allergies to the ingredients in Pentasa Sachet 1 gm. Caution is advised when using Pentasa Sachet 1 gm in elderly patients. If you are pregnant or breastfeeding, please inform your doctor prior to taking Pentasa Sachet 1 gm. Avoid using Pentasa Sachet 1 gm if you suffer from severe kidney failure. If you experience stomach pain, cramps, severe headache, fever, or rash after taking Pentasa Sachet 1 gm, discontinue use immediately and seek medical advice.
